Shares of ONT, the environmental solutions company formerly known as Montrose Environmental Group, cratered roughly 36.19% on Thursday, sinking to approximately $14.44 after closing the prior session at $22.63. The collapse extends a punishing after-hours reaction to the company's second-quarter 2026 earnings release late Tuesday, which missed analyst expectations and included a dramatic downward revision to full-year revenue and EBITDA guidance. A subsequent analyst downgrade from BofA Securities and the surprise announcement of a stockholder rights plan compounded the selling pressure, making this one of the worst single-session performances in the company's public history.
The rout originated after Tuesday's closing bell, when ONT reported second-quarter revenue of $186.7 million—a steep 20.4% decline from $234.5 million in the year-earlier period and well short of the $200.45 million Wall Street consensus. Adjusted earnings per share landed at just $0.04, missing the $0.09 estimate by a wide margin. The company attributed the shortfall primarily to historically low environmental emergency response and recovery service activity, which fell roughly $37.7 million year-over-year. Management stressed that the decline was driven by the timing and frequency of environmental events rather than competitive losses, but investors showed little patience for that distinction.
Although the company managed to expand its consolidated adjusted EBITDA margin by 20 basis points to 17.1%—thanks to ongoing cost-optimization efforts—the improvement was overshadowed by the sheer magnitude of the top-line miss. The Consulting & Treatment segment bore the brunt of the damage, with revenue plunging 26.8% to $125.6 million, while the Measurement & Analysis segment held relatively steady at $61.1 million, down just 2.7%.
Compounding the quarterly disappointment, ONT management dramatically reduced its full-year 2026 outlook. Revenue guidance was cut to a range of $740 million to $790 million, down from the previous range of $840 million to $900 million—a roughly $115 million reduction at the midpoint. Full-year EBITDA guidance was also trimmed to $117 million to $120 million from $125 million to $130 million. The guidance cut reflected three primary headwinds: approximately $45 million in lower pass-through revenue, about $40 million less emergency response revenue, and roughly $20 million in other revenue impacts tied to temporary regulatory waivers for federal and state air permitting rules.
For the third quarter, the company forecast revenue of $190 million to $210 million with EBITDA margins between 17% and 18%. While management maintained that every outcome in the updated EBITDA range would represent a company record, the market focused squarely on the downward trajectory.
The selling intensified on Thursday after BofA Securities downgraded ONT from Neutral to Underperform and slashed its price target from $31 to $18. The firm cited accelerating federal deregulation under the current administration, arguing that a broad-based rollback of environmental regulations through the EPA and other agencies is likely to encourage private-sector companies to adopt a "wait-and-see" approach toward environmental spending. BofA also flagged execution risks, noting that recent performance and below-peer margin expansion justified a discount to target valuation multiples. The firm lowered its valuation methodology to 10 times estimated 2027 EBITDA, down from 17 times previously.
In a move that added a layer of corporate intrigue, ONT announced alongside its earnings that the board had adopted a limited-duration stockholder rights plan—commonly known as a poison pill—effective immediately and expiring in August 2027. The company cited "significant and undisclosed accumulation of Onterris shares and derivative securities" as the reason. Simultaneously, the board launched a comprehensive strategic review encompassing the business portfolio, capital allocation, long-range planning, and strategic alternatives, including the possible evaluation of acquisition interest. While no decision has been made and no timeline set, the combination of a poison pill and a strategic review introduced a new layer of uncertainty that likely contributed to Thursday's selling.
Thursday's collapse was extraordinary by any measure. After falling roughly 18% in after-hours trading on Tuesday to around $18.56, the stock gapped down further at Thursday's open and continued to slide through the session, touching levels near the 52-week low of $14.13. Volume was significantly elevated, with early data suggesting trading activity well above the 10-day average of roughly 429,000 shares. The move was entirely company-specific; broader equity indices traded relatively flat on Thursday, and no sector-wide catalyst explained the magnitude of ONT's decline. The stock had been on a strong run in recent months, rallying roughly 40% over the prior three months before this week's collapse erased those gains in a single session.
The immediate focus for ONT shareholders will be whether the stock can stabilize above the $14.13 52-week low, which now serves as a critical psychological and technical support level. The board's strategic review process will remain a central storyline in the months ahead, with investors watching for any indication of takeover interest, asset sales, or other value-creating transactions. Third-quarter results, expected later this fall, will provide the next major test of whether emergency response activity and regulatory-driven revenue can rebound. Key risks include the persistence of the deregulatory environment, the unpredictable nature of environmental events that drive emergency response revenue, and the execution risk inherent in the company's cost-optimization program. While management projects strong second-half cash flow generation, rebuilding investor confidence will likely require multiple quarters of improved execution.
For traders navigating volatile situations like the one unfolding in ONT, Tickeron offers a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers. The Trending AI Robots page features only the strongest-performing bots under current market conditions, spanning a variety of strategies, timeframes, and performance metrics. Each bot is tailored to a specific trading style—whether momentum, trend-following, or mean-reversion—allowing users to find automated solutions aligned with their approach. Explore the Trending AI Robots page to discover which strategies are outperforming in today's market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for ONT crossed bullishly above the 50-day moving average on June 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on ONT as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ONT just turned positive on August 03, 2026. Looking at past instances where ONT's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONT advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 199 cases where ONT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for ONT moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ONT broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.858) is normal, around the industry mean (5.386). P/E Ratio (150.867) is within average values for comparable stocks, (104.706). ONT's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.085). ONT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.009). P/S Ratio (0.978) is also within normal values, averaging (77.083).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the provision of air measurement and environmental laboratory services
Industry EnvironmentalServices